Exosome treatment for severe dry eyes in Sjögren's syndrome
Part of Bones, joints & muscles, Eyes & vision, Immune system & allergy, Mouth & dental, Skin clinical trials.
This early-phase trial tests whether a new treatment using exosomes (tiny natural particles) given as eye drops or injections can help people with Sjögren's syndrome who have severe dry eyes that haven't responded to usual treatments. The goal is to see if it's safe and to get early hints of whether it relieves eye symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must have Sjögren's syndrome with eye involvement (like severe dry eyes).
- Standard treatments like artificial tears or steroids haven't helped your eye symptoms for at least 3 months.
- Your Sjögren's symptoms outside the eyes should be stable.
- You must be willing to use effective birth control during the study and for 6 months after the last dose.
- You cannot have other serious eye diseases, recent eye surgery, or certain medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental eye drop made from stem cells to see if it can help with the severe dry eye symptoms of Sjögren's syndrome. It might be an option if standard treatments like artificial tears haven't worked well for you.
This trial tests a new eye drop made from a natural protein (rhPRG4) to see if it safely and effectively relieves dry eye symptoms in people with Sjögren's syndrome. You'll be randomly assigned to receive the study drop or a placebo (inactive) drop for several weeks.
This study looks at tiny particles called exosomes in tears to find new ways to diagnose or treat Sjogren's syndrome and dry eye disease. It may help people with these conditions by learning more about what causes them.
This trial tests a new treatment using stem cells and exosomes (tiny healing particles) injected into the salivary glands under the jaw. It aims to improve saliva production and relieve dry mouth in people with primary Sjögren syndrome.
This trial tests if using special eye drops (cyclosporine) along with tiny plugs placed in the tear ducts can improve dry eye symptoms in people with Sjögren's syndrome. The goal is to see if this combination works better than the drops alone.
This study tests a new medicine called ESG206, which is designed to calm the immune system and reduce the symptoms of Sjögren's syndrome. If you join, you may get this medicine or a placebo, and the study will see if it safely helps with things like dry eyes and dry mouth.
Hear when a new Sjögren's Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.